RETRACTION article

Front. Oncol., 16 July 2024

Sec. Gastrointestinal Cancers

Volume 14 - 2024 | https://doi.org/10.3389/fonc.2024.1459966

Retraction: Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma

Article metrics

View details

1,6k

Views

500

Downloads

The journal retracts the 18 June 2021 article cited above.

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. As a result, the data and conclusions of the article have been deemed unreliable and the article has been retracted.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors received a communication regarding the retraction and had a chance to respond. This communication has been recorded by the publisher.

Summary

Keywords

Stomach adenocarcinoma (STAD), WGCNA, early diagnosis, TCGA, biomarkers, prognosis

Citation

Frontiers Editorial Office (2024) Retraction: Identification of early diagnostic and prognostic biomarkers via WGCNA in stomach adenocarcinoma. Front. Oncol. 14:1459966. doi: 10.3389/fonc.2024.1459966

Received

05 July 2024

Accepted

05 July 2024

Published

16 July 2024

Approved by

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Volume

14 - 2024

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics